Damien Botsen

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Small Cell Lung Cancer

Placebo Controlled

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Christelle De La Fouchardière, David Malka, Claire Cropet, Sylvie Chabaud, Judith Raimbourg, Damien Botsen, Simon Launay, Ludovic Evesque, Angélique Vienot, Hervé Perrier, Marine Jary, Yves Rinaldi, Clélia Coutzac, Jean Baptiste Bachet, Cindy Neuzillet, Nicolas Williet, Romain Desgrippes, Thomas Grainville, Thomas Aparicio, Annie Peytier, Thierry Lecomte, Gaël S Roth, Anne Thirot-Bidault, Nicolas Lachaux, Olivier Bouche, François Ghiringhelli
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Christelle De La Fouchardière, David Malka, Claire Cropet, Sylvie Chabaud, Judith Raimbourg, Damien Botsen, Simon Launay, Ludovic Evesque, Angélique Vienot, Hervé Perrier, Marine Jary, Yves Rinaldi, Clélia Coutzac, Jean Baptiste Bachet, Cindy Neuzillet, Nicolas Williet, Romain Desgrippes, Thomas Grainville, Thomas Aparicio, Annie Peytier, Thierry Lecomte, Gaël S Roth, Anne Thirot-Bidault, Nicolas Lachaux, Olivier Bouche, François Ghiringhelli
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (9) (2024)
Christelle De La Fouchardière, David Malka, Claire Cropet, Sylvie Chabaud, Judith Raimbourg, Damien Botsen, Simon Launay, Ludovic Evesque, Angélique Vienot, Hervé Perrier, Marine Jary, Yves Rinaldi, Clélia Coutzac, Jean Baptiste Bachet, Cindy Neuzillet, Nicolas Williet, Romain Desgrippes, Thomas Grainville, Thomas Aparicio, Annie Peytier, Thierry Lecomte, Gaël S Roth, Anne Thirot-Bidault, Nicolas Lachaux, Olivier Bouche, François Ghiringhelli
Gemcitabine and Paclitaxel Versus Gemcitabine Alone After 5-Fluorouracil, Oxaliplatin, and Irinotecan in Metastatic Pancreatic Adenocarcinoma: A Randomized Phase III PRODIGE 65-UCGI 36-GEMPAX UNICANCER Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Johanna Moreau, Marie-Amélie Ordan, Coralie Barbe, Camille Mazza, Marine Perrier, Damien Botsen, Mathilde Brasseur, Christophe Portefaix, Yohann Renard, Barbara Tallière, Eric Bertin, Christine Hoeffel, Olivier Bouché
Correlation between muscle mass and handgrip strength in digestive cancer patients undergoing chemotherapy. Cancer medicine 8 (8) (2019)
Damien Botsen, Elise Lepoix, Camille Mazza, Mathilde Brasseur, Anne Grange, Florian Slimano, Olivier Bouché
Oxaliplatin-desensitization procedure is safe and feasible in an outpatient cancer unit in France. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 27 (9) (2019)
Damien Botsen, Marie-Amélie Ordan, Coralie Barbe, Camille Mazza, Marine Perrier, Johanna Moreau, Mathilde Brasseur, Yohann Renard, Barbara Taillière, Florian Slimano, Eric Bertin, Olivier Bouché
Dynapenia could predict chemotherapy-induced dose-limiting neurotoxicity in digestive cancer patients. BMC cancer 18 (1) (2018)